drugset / Trial / NCT01022242
Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
The objectives of the study are to assess efficacy, safety, and handling of PXL01 in patients with flexor tendon injury in zone I or II.
Timeline
- Start
- 2009-12
- Primary completion
- 2012-05
- Completion
- 2013-02
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs PXL01; p = 0.8861; ANCOVA NCT01022242 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENSEREPTIDE | Peptide | 0.5 ml | Other |
Indications
No indication recorded.